<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Cyanopindolol</id>
	<title>Cyanopindolol - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Cyanopindolol"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Cyanopindolol&amp;action=history"/>
	<updated>2026-04-27T07:22:10Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Cyanopindolol&amp;diff=5649118&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Cyanopindolol&amp;diff=5649118&amp;oldid=prev"/>
		<updated>2024-04-23T20:12:51Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Cyanopindolol.svg|Cyanopindolol|thumb]] &amp;#039;&amp;#039;&amp;#039;Cyanopindolol&amp;#039;&amp;#039;&amp;#039; is a synthetic compound that belongs to the class of [[beta blocker]]s, which are medications commonly used in the treatment of various cardiovascular conditions such as [[hypertension]], [[angina pectoris]], and certain types of [[cardiac arrhythmias]]. Cyanopindolol, like other beta blockers, works by blocking the action of [[epinephrine]] (adrenaline) and [[norepinephrine]] (noradrenaline) on the [[beta-adrenergic receptor]], thereby reducing heart rate, cardiac output, and blood pressure.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
Cyanopindolol exhibits both antagonist and partial agonist activity at the beta-adrenergic receptor. It is characterized by its high affinity for both [[Beta-1 adrenergic receptor|beta-1]] and [[Beta-2 adrenergic receptor|beta-2 adrenergic receptors]], which are found in the heart and in the smooth muscle of the lungs and vasculature, respectively. This dual action makes it a unique tool in research, especially in studies aimed at understanding the physiological and pathological roles of beta-adrenergic receptors.&lt;br /&gt;
&lt;br /&gt;
==Clinical Use==&lt;br /&gt;
The clinical applications of cyanopindolol are limited compared to other beta blockers due to its experimental nature and the availability of other agents with better-characterized profiles for treating cardiovascular diseases. However, it has been used in clinical research to explore its potential benefits in treating conditions such as [[cardiac arrhythmias]] and to investigate its effects on cardiac function and blood pressure regulation.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
As with other beta blockers, the use of cyanopindolol can be associated with a range of side effects, although its specific side effect profile may vary due to its partial agonist activity. Common side effects of beta blockers include [[fatigue]], [[dizziness]], [[cold extremities]], and [[bradycardia]] (slow heart rate). Due to its action on beta-2 adrenergic receptors, cyanopindolol may also cause bronchospasm, particularly in patients with underlying respiratory conditions such as [[asthma]].&lt;br /&gt;
&lt;br /&gt;
==Research==&lt;br /&gt;
Cyanopindolol has been a valuable tool in pharmacological research, particularly in studies aimed at dissecting the signaling pathways mediated by beta-adrenergic receptors. Its ability to act as both an antagonist and a partial agonist allows researchers to explore the complex dynamics of receptor activation and inhibition in various physiological and pathological processes.&lt;br /&gt;
&lt;br /&gt;
[[Category:Beta blockers]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>